| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.568 | 0.01 | 0.573 | Hypoglycemic | 0.573 0.01 CID_10013772 | CID_10013772 | |
| 0.538 | 0.022 | 0.54 | 5 Hydroxytryptamine release stimulant | 0.54 0.021 CID_10013772 | CID_10013772 | |
| 0.39 | 0.024 | 0.4 | Insulysin inhibitor | 0.4 0.022 CID_10013772 | CID_10013772 | |
| 0.376 | 0.019 | 0.376 | 5 Hydroxytryptamine uptake stimulant | 0.366 0.021 CID_10013772 | ||
| 0.371 | 0.034 | 0.371 | Cardiotonic | 0.288 0.062 CID_10013772 | ||
| 0.343 | 0.038 | 0.421 | Superoxide dismutase inhibitor | 0.421 0.023 CID_10013772 | CID_10013772 | |
| 0.374 | 0.073 | 0.407 | GABA C receptor rho-3 antagonist | 0.407 0.059 CID_10013772 | CID_10013772 | |
| 0.314 | 0.013 | 0.314 | Nav1.2 sodium channel blocker | 0.245 0.023 CID_10013772 | ||
| 0.323 | 0.024 | 0.399 | Tyrosine 3 hydroxylase inhibitor | 0.399 0.008 CID_10013772 | CID_10013772 | |
| 0.305 | 0.009 | 0.305 | GABA C receptor agonist | 0.292 0.01 CID_10013772 | ||
| 0.299 | 0.005 | 0.299 | CXC chemokine 4 receptor antagonist | 0.24 0.008 CID_10013772 | ||
| 0.271 | 0.004 | 0.271 | 5 Hydroxytryptamine 3A agonist | 0.253 0.005 CID_10013772 | ||
| 0.377 | 0.122 | 0.377 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.259 | 0.027 | 0.282 | Nitric-oxide synthase stimulant | 0.282 0.016 CID_10013772 | CID_10013772 | |
| 0.244 | 0.014 | 0.244 | Ferrochelatase inhibitor | 0.144 0.04 CID_10013772 | ||
| 0.232 | 0.003 | 0.232 | Vanilloid 2 antagonist | 0.198 0.003 CID_10013772 | ||
| 0.228 | 0.006 | 0.228 | Melanocortin antagonist | 0.085 0.013 CID_10013772 | ||
| 0.242 | 0.02 | 0.242 | 5 Hydroxytryptamine 3E antagonist | 0.194 0.074 CID_10013772 | ||
| 0.242 | 0.023 | 0.278 | Neurotensin receptor agonist | 0.278 0.017 CID_10013772 | CID_10013772 | |
| 0.221 | 0.004 | 0.221 | Factor V inhibitor | 0.193 0.006 CID_10013772 | ||
| 0.231 | 0.015 | 0.231 | Aminopeptidase B inhibitor | 0.231 0.015 CID_10013772 | ||
| 0.336 | 0.128 | 0.359 | 5 Hydroxytryptamine release inhibitor | 0.359 0.108 CID_10013772 | CID_10013772 | |
| 0.256 | 0.051 | 0.256 | Neuropeptide Y2 antagonist | 0.252 0.054 CID_10013772 | ||
| 0.21 | 0.006 | 0.21 | Melanocortin 3 antagonist | 0.082 0.012 CID_10013772 | ||
| 0.203 | 0.006 | 0.203 | Plasmin inhibitor | 0.14 0.011 CID_10013772 | ||
| 0.241 | 0.049 | 0.446 | Peroxidase inhibitor | 0.446 0.015 CID_10013772 | CID_10013772 | |
| 0.198 | 0.009 | 0.309 | NMDA 2 receptor antagonist | 0.309 0.005 CID_10013772 | CID_10013772 | |
| 0.206 | 0.021 | 0.206 | Cathepsin H inhibitor | 0.172 0.033 CID_10013772 | ||
| 0.192 | 0.007 | 0.305 | Phenylalanine 4-hydroxylase inhibitor | 0.305 0.004 CID_10013772 | CID_10013772 | |
| 0.188 | 0.004 | 0.188 | Protease activated receptor 1 antagonist | 0.139 0.007 CID_10013772 | ||
| 0.201 | 0.017 | 0.201 | Falcipain 3 inhibitor | 0.187 0.022 CID_10013772 | ||
| 0.19 | 0.011 | 0.19 | Nitric-oxide synthase inhibitor | 0.144 0.025 CID_10013772 | ||
| 0.272 | 0.096 | 0.311 | Interleukin 2 agonist | 0.311 0.066 CID_10013772 | CID_10013772 | |
| 0.183 | 0.007 | 0.183 | Thrombin inhibitor | 0.128 0.015 CID_10013772 | ||
| 0.175 | 0.004 | 0.175 | Melanocortin 5 antagonist | 0.077 0.009 CID_10013772 | ||
| 0.317 | 0.147 | 0.362 | Cyclophilin D inhibitor | 0.362 0.114 CID_10013772 | CID_10013772 | |
| 0.172 | 0.005 | 0.172 | Urokinase inhibitor | 0.14 0.008 CID_10013772 | ||
| 0.169 | 0.004 | 0.169 | Complement C3a chemotactic receptor antagonist | 0.126 0.005 CID_10013772 | ||
| 0.16 | 0.003 | 0.16 | Epithelial sodium channel blocker | 0.153 0.003 CID_10013772 | ||
| 0.159 | 0.006 | 0.159 | Melanocortin 4 antagonist | 0.073 0.014 CID_10013772 | ||
| 0.181 | 0.029 | 0.183 | Neuropeptide Y1 antagonist | 0.183 0.027 CID_10013772 | CID_10013772 | |
| 0.162 | 0.014 | 0.162 | Inducible nitric-oxide synthase inhibitor | 0.124 0.023 CID_10013772 | ||
| 0.271 | 0.123 | 0.271 | Calcium channel activator | 0.252 0.144 CID_10013772 | ||
| 0.23 | 0.085 | 0.23 | Calpain inhibitor | 0.197 0.117 CID_10013772 | ||
| 0.301 | 0.157 | 0.418 | Calcium channel L-type activator | 0.418 0.069 CID_10013772 | CID_10013772 | |
| 0.176 | 0.032 | 0.209 | Adenylate cyclase inhibitor | 0.209 0.024 CID_10013772 | CID_10013772 | |
| 0.153 | 0.012 | 0.153 | Neuropeptide agonist | 0.141 0.016 CID_10013772 | ||
| 0.207 | 0.067 | 0.227 | Insulin sensitizer | 0.227 0.05 CID_10013772 | CID_10013772 | |
| 0.23 | 0.095 | 0.23 | Interleukin agonist | 0.22 0.103 CID_10013772 | ||
| 0.17 | 0.035 | 0.191 | Adenylate cyclase stimulant | 0.191 0.018 CID_10013772 | CID_10013772 | |
| 0.138 | 0.006 | 0.138 | Protease activated receptor antagonist | 0.094 0.016 CID_10013772 | ||
| 0.135 | 0.005 | 0.135 | Histamine agonist | 0.063 0.025 CID_10013772 | ||
| 0.242 | 0.113 | 0.242 | Ca(v)3.3 blocker | |||
| 0.309 | 0.184 | 0.373 | Caspase 9 stimulant | 0.373 0.128 CID_10013772 | CID_10013772 | |
| 0.143 | 0.018 | 0.143 | CYP2A6 inhibitor | 0.084 0.045 CID_10013772 | ||
| 0.141 | 0.018 | 0.141 | Histamine N-methyltransferase inhibitor | 0.133 0.022 CID_10013772 | ||
| 0.126 | 0.005 | 0.126 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.099 0.014 CID_10013772 | ||
| 0.121 | 0.003 | 0.121 | Histamine H2 receptor agonist | 0.082 0.007 CID_10013772 | ||
| 0.148 | 0.031 | 0.148 | GABA C receptor antagonist | 0.144 0.033 CID_10013772 | ||
| 0.134 | 0.019 | 0.2 | Opioid kappa receptor antagonist | 0.2 0.01 CID_10013772 | CID_10013772 | |
| 0.122 | 0.008 | 0.122 | 5 Hydroxytryptamine 3 agonist | 0.097 0.017 CID_10013772 | ||
| 0.163 | 0.051 | 0.163 | Histone deacetylase SIRT1 inhibitor | 0.161 0.053 CID_10013772 | ||
| 0.117 | 0.005 | 0.117 | Complement C5a chemotactic receptor antagonist | 0.043 0.011 CID_10013772 | ||
| 0.113 | 0.004 | 0.113 | Diamine oxidase inhibitor | 0.07 0.007 CID_10013772 | ||
| 0.136 | 0.029 | 0.136 | GABA C receptor rho-1 antagonist | 0.122 0.038 CID_10013772 | ||
| 0.117 | 0.01 | 0.117 | 5 Hydroxytryptamine 2A agonist | 0.11 0.011 CID_10013772 | ||
| 0.139 | 0.034 | 0.139 | Nav1.5 sodium channel blocker | 0.109 0.069 CID_10013772 | ||
| 0.129 | 0.024 | 0.187 | Opioid delta receptor antagonist | 0.187 0.013 CID_10013772 | CID_10013772 | |
| 0.116 | 0.012 | 0.116 | Plasminogen activator inhibitor | 0.101 0.015 CID_10013772 | ||
| 0.166 | 0.062 | 0.186 | Hexokinase inhibitor | 0.186 0.044 CID_10013772 | CID_10013772 | |
| 0.115 | 0.012 | 0.115 | Trypsin inhibitor | 0.094 0.02 CID_10013772 | ||
| 0.114 | 0.012 | 0.141 | NMDA 2C receptor antagonist | 0.141 0.008 CID_10013772 | CID_10013772 | |
| 0.132 | 0.031 | 0.186 | Opioid antagonist | 0.186 0.017 CID_10013772 | CID_10013772 | |
| 0.214 | 0.115 | 0.214 | 5 Hydroxytryptamine 1E antagonist | 0.202 0.129 CID_10013772 | ||
| 0.215 | 0.118 | 0.246 | Transcription factor STAT inhibitor | 0.246 0.089 CID_10013772 | CID_10013772 | |
| 0.12 | 0.025 | 0.238 | Histidine decarboxylase inhibitor | 0.238 0.01 CID_10013772 | CID_10013772 | |
| 0.116 | 0.023 | 0.116 | Histamine H2 receptor antagonist | 0.088 0.05 CID_10013772 | ||
| 0.107 | 0.017 | 0.107 | Carbonic anhydrase I inhibitor | 0.102 0.018 CID_10013772 | ||
| 0.113 | 0.023 | 0.165 | Glutamate decarboxylase inhibitor | 0.165 0.01 CID_10013772 | CID_10013772 | |
| 0.11 | 0.023 | 0.11 | Aminopeptidase I inhibitor | 0.105 0.025 CID_10013772 | ||
| 0.102 | 0.015 | 0.102 | 5 Hydroxytryptamine 5A antagonist | 0.076 0.026 CID_10013772 | ||
| 0.124 | 0.041 | 0.175 | DOPA decarboxylase inhibitor | 0.175 0.012 CID_10013772 | CID_10013772 | |
| 0.111 | 0.029 | 0.111 | Factor XII inhibitor | 0.099 0.039 CID_10013772 | ||
| 0.161 | 0.079 | 0.196 | Growth hormone agonist | 0.196 0.06 CID_10013772 | CID_10013772 | |
| 0.11 | 0.028 | 0.163 | Opioid mu receptor antagonist | 0.163 0.015 CID_10013772 | CID_10013772 | |
| 0.087 | 0.006 | 0.087 | Melanocortin 3 agonist | 0.044 0.013 CID_10013772 | ||
| 0.096 | 0.016 | 0.096 | 5 Hydroxytryptamine 5 antagonist | 0.068 0.028 CID_10013772 | ||
| 0.095 | 0.015 | 0.136 | NMDA 2A receptor antagonist | 0.136 0.008 CID_10013772 | CID_10013772 | |
| 0.095 | 0.015 | 0.103 | Neurotensin receptor antagonist | 0.103 0.014 CID_10013772 | CID_10013772 | |
| 0.089 | 0.011 | 0.099 | Sphingosine kinase 2 inhibitor | 0.099 0.008 CID_10013772 | CID_10013772 | |
| 0.109 | 0.032 | 0.153 | Porphobilinogen synthase inhibitor | 0.153 0.02 CID_10013772 | CID_10013772 | |
| 0.115 | 0.038 | 0.187 | NMDA receptor antagonist | 0.187 0.016 CID_10013772 | CID_10013772 | |
| 0.096 | 0.021 | 0.11 | Carbonic anhydrase XII inhibitor | 0.11 0.018 CID_10013772 | CID_10013772 | |
| 0.149 | 0.074 | 0.149 | GABA C receptor rho-2 antagonist | 0.142 0.084 CID_10013772 | ||
| 0.138 | 0.063 | 0.138 | Alpha-N-acetylglucosaminidase inhibitor | 0.121 0.077 CID_10013772 | ||
| 0.083 | 0.009 | 0.083 | Melanocortin 5 agonist | 0.023 0.015 CID_10013772 | ||
| 0.161 | 0.086 | 0.19 | Phospholipase C inhibitor | 0.19 0.052 CID_10013772 | CID_10013772 | |
| 0.094 | 0.02 | 0.095 | Carbonic anhydrase II inhibitor | 0.095 0.02 CID_10013772 | CID_10013772 | |
| 0.077 | 0.004 | 0.077 | Histamine H1 receptor agonist | 0.049 0.021 CID_10013772 | ||
| 0.078 | 0.005 | 0.078 | Endothelial nitric-oxide synthase inhibitor | 0.035 0.017 CID_10013772 | ||
| 0.114 | 0.043 | 0.125 | HIV-1 integrase (Overall Integration) inhibitor | 0.125 0.036 CID_10013772 | CID_10013772 | |
| 0.098 | 0.028 | 0.104 | Carbonic anhydrase inhibitor | 0.104 0.026 CID_10013772 | CID_10013772 | |
| 0.085 | 0.015 | 0.085 | Histone deacetylase SIRT3 inhibitor | 0.075 0.022 CID_10013772 | ||
| 0.098 | 0.028 | 0.127 | Estrogen-related receptor beta agonist | 0.127 0.007 CID_10013772 | CID_10013772 | |
| 0.09 | 0.02 | 0.09 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.167 | 0.097 | 0.184 | Anesthetic general | 0.184 0.084 CID_10013772 | CID_10013772 | |
| 0.076 | 0.007 | 0.127 | Dopamine D5 agonist | 0.127 0.003 CID_10013772 | CID_10013772 | |
| 0.089 | 0.022 | 0.089 | Carbonic anhydrase stimulant | 0.069 0.032 CID_10013772 | ||
| 0.115 | 0.048 | 0.115 | Adenylate kinase inhibitor | 0.104 0.061 CID_10013772 | ||
| 0.116 | 0.05 | 0.158 | Carbonic anhydrase XV inhibitor | 0.158 0.028 CID_10013772 | CID_10013772 | |
| 0.073 | 0.007 | 0.073 | Tryptase inhibitor | 0.043 0.018 CID_10013772 | ||
| 0.142 | 0.077 | 0.142 | Thiol protease inhibitor | |||
| 0.088 | 0.022 | 0.088 | Potassium channel (ATP-sensitive) blocker | 0.082 0.027 CID_10013772 | ||
| 0.088 | 0.022 | 0.088 | Argininosuccinate synthase inhibitor | 0.075 0.027 CID_10013772 | ||
| 0.074 | 0.01 | 0.074 | Melanocortin agonist | 0.027 0.018 CID_10013772 | ||
| 0.116 | 0.053 | 0.15 | AMP-activated protein kinase stimulant | 0.15 0.029 CID_10013772 | CID_10013772 | |
| 0.096 | 0.035 | 0.096 | Cathepsin G inhibitor | 0.092 0.037 CID_10013772 | ||
| 0.198 | 0.137 | 0.221 | Transcription factor STAT3 inhibitor | 0.221 0.11 CID_10013772 | CID_10013772 | |
| 0.064 | 0.004 | 0.064 | Tryptophan 5 hydroxylase inhibitor | 0.051 0.005 CID_10013772 | ||
| 0.063 | 0.003 | 0.063 | Sodium/hydrogen exchanger inhibitor | 0.036 0.004 CID_10013772 | ||
| 0.069 | 0.011 | 0.069 | Immunoglobulin Fc receptor antagonist | 0.063 0.019 CID_10013772 | ||
| 0.083 | 0.025 | 0.083 | Carbonic anhydrase IX inhibitor | 0.082 0.026 CID_10013772 | ||
| 0.157 | 0.099 | 0.169 | Succinate dehydrogenase inhibitor | 0.169 0.082 CID_10013772 | CID_10013772 | |
| 0.091 | 0.034 | 0.111 | GABA aminotransferase inhibitor | 0.111 0.02 CID_10013772 | CID_10013772 | |
| 0.107 | 0.052 | 0.182 | Creatine kinase inhibitor | 0.182 0.014 CID_10013772 | CID_10013772 | |
| 0.118 | 0.063 | 0.125 | Transcription factor STAT6 inhibitor | 0.125 0.051 CID_10013772 | CID_10013772 | |
| 0.075 | 0.021 | 0.078 | Botulinum neurotoxin type A inhibitor | 0.078 0.018 CID_10013772 | CID_10013772 | |
| 0.095 | 0.041 | 0.104 | Myeloperoxidase inhibitor | 0.104 0.03 CID_10013772 | CID_10013772 | |
| 0.116 | 0.063 | 0.131 | TRPA1 agonist | 0.131 0.046 CID_10013772 | CID_10013772 | |
| 0.084 | 0.031 | 0.084 | Secretase beta inhibitor | 0.066 0.058 CID_10013772 | ||
| 0.067 | 0.016 | 0.067 | Factor X inhibitor | |||
| 0.06 | 0.01 | 0.06 | Factor VII inhibitor | 0.037 0.016 CID_10013772 | ||
| 0.059 | 0.009 | 0.059 | Melanocortin 4 agonist | 0.022 0.018 CID_10013772 | ||
| 0.102 | 0.053 | 0.131 | Prolactin inhibitor | 0.131 0.032 CID_10013772 | CID_10013772 | |
| 0.053 | 0.007 | 0.053 | Lysine carboxypeptidase inhibitor | 0.052 0.007 CID_10013772 | ||
| 0.061 | 0.016 | 0.067 | Oxytocin agonist | 0.067 0.011 CID_10013772 | CID_10013772 | |
| 0.053 | 0.008 | 0.053 | Thrombin receptor antagonist | 0.03 0.017 CID_10013772 | ||
| 0.056 | 0.012 | 0.059 | Arginase inhibitor | 0.059 0.011 CID_10013772 | CID_10013772 | |
| 0.155 | 0.112 | 0.155 | Psychostimulant | 0.142 0.124 CID_10013772 | ||
| 0.053 | 0.011 | 0.053 | Trypsin I inhibitor | 0.041 0.017 CID_10013772 | ||
| 0.068 | 0.025 | 0.068 | Kallikrein 1 inhibitor | 0.058 0.036 CID_10013772 | ||
| 0.083 | 0.042 | 0.083 | Glutamate dehydrogenase inhibitor | 0.082 0.043 CID_10013772 | ||
| 0.135 | 0.095 | 0.145 | Heat shock protein 70 antagonist | 0.145 0.058 CID_10013772 | CID_10013772 | |
| 0.05 | 0.01 | 0.05 | 5 Hydroxytryptamine 1D agonist | |||
| 0.068 | 0.028 | 0.076 | Sphingosine kinase inhibitor | 0.076 0.019 CID_10013772 | CID_10013772 | |
| 0.09 | 0.051 | 0.09 | Granulocyte macrophage colony stimulating factor agonist | 0.088 0.056 CID_10013772 | ||
| 0.067 | 0.027 | 0.067 | Ornithine carbamoyltransferase inhibitor | 0.054 0.036 CID_10013772 | ||
| 0.211 | 0.172 | 0.221 | Vasodilator, coronary | 0.221 0.163 CID_10013772 | CID_10013772 | |
| 0.042 | 0.005 | 0.042 | Histamine H4 receptor agonist | |||
| 0.051 | 0.014 | 0.051 | Melanocortin 1 agonist | |||
| 0.092 | 0.054 | 0.099 | NADH dehydrogenase inhibitor | 0.099 0.045 CID_10013772 | CID_10013772 | |
| 0.069 | 0.032 | 0.069 | Biliverdin reductase inhibitor | 0.053 0.049 CID_10013772 | ||
| 0.065 | 0.029 | 0.065 | Cyclin A1 inhibitor | |||
| 0.061 | 0.025 | 0.061 | Aconitate hydratase inhibitor | 0.048 0.042 CID_10013772 | ||
| 0.053 | 0.019 | 0.053 | Melanocortin 1 antagonist | 0.037 0.027 CID_10013772 | ||
| 0.134 | 0.1 | 0.134 | Ca2+-transporting ATPase inhibitor | 0.133 0.103 CID_10013772 | ||
| 0.038 | 0.005 | 0.038 | Imidazoline I1 receptor antagonist | |||
| 0.054 | 0.023 | 0.063 | Dopamine beta hydroxylase inhibitor | 0.063 0.012 CID_10013772 | CID_10013772 | |
| 0.079 | 0.049 | 0.1 | MAP kinase kinase 7 inhibitor | 0.1 0.013 CID_10013772 | CID_10013772 | |
| 0.062 | 0.032 | 0.062 | Acyl-CoA dehydrogenase inhibitor | 0.047 0.046 CID_10013772 | ||
| 0.066 | 0.036 | 0.066 | Calcium channel P-type blocker | |||
| 0.048 | 0.018 | 0.059 | Dihydropteroate synthase inhibitor | 0.059 0.012 CID_10013772 | CID_10013772 | |
| 0.063 | 0.033 | 0.131 | Alcohol oxidase inhibitor | 0.131 0.012 CID_10013772 | CID_10013772 | |
| 0.033 | 0.007 | 0.033 | Protease activated receptor agonist | 0.019 0.012 CID_10013772 | ||
| 0.051 | 0.025 | 0.051 | Mannosidase inhibitor | 0.05 0.025 CID_10013772 | ||
| 0.04 | 0.014 | 0.04 | Dipeptidyl peptidase II inhibitor | |||
| 0.088 | 0.063 | 0.088 | Triose-phosphate isomerase inhibitor | 0.084 0.07 CID_10013772 | ||
| 0.043 | 0.017 | 0.046 | Phosphoglycerate kinase inhibitor | 0.046 0.015 CID_10013772 | CID_10013772 | |
| 0.158 | 0.132 | 0.323 | Aldehyde oxidase inhibitor | 0.323 0.061 CID_10013772 | CID_10013772 | |
| 0.062 | 0.037 | 0.062 | Cathepsin L inhibitor | |||
| 0.048 | 0.023 | 0.048 | Glutamate (mGluR4) antagonist | |||
| 0.038 | 0.015 | 0.038 | Carboxypeptidase B inhibitor | 0.035 0.02 CID_10013772 | ||
| 0.032 | 0.008 | 0.032 | Integrin beta5 antagonist | 0.021 0.014 CID_10013772 | ||
| 0.073 | 0.05 | 0.073 | Telomerase inhibitor | |||
| 0.063 | 0.04 | 0.063 | Carbamoyl phosphate synthetase inhibitor | 0.059 0.044 CID_10013772 | ||
| 0.069 | 0.046 | 0.069 | Exportin-1 inhibitor | |||
| 0.089 | 0.067 | 0.089 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | |||
| 0.119 | 0.098 | 0.119 | Sphingosine 1-phosphate receptor 2 antagonist | 0.119 0.098 CID_10013772 | ||
| 0.099 | 0.078 | 0.119 | Nav1.4 sodium channel blocker | 0.119 0.053 CID_10013772 | CID_10013772 | |
| 0.153 | 0.133 | 0.205 | Neurotrophic factor enhancer | 0.205 0.071 CID_10013772 | CID_10013772 | |
| 0.044 | 0.024 | 0.045 | Sphingosine kinase 1 inhibitor | 0.045 0.022 CID_10013772 | CID_10013772 | |
| 0.169 | 0.149 | 0.221 | Peptidyltransferase inhibitor | 0.221 0.075 CID_10013772 | CID_10013772 | |
| 0.024 | 0.004 | 0.024 | Tryptophan hydroxylase 1 inhibitor | 0.02 0.007 CID_10013772 | ||
| 0.023 | 0.004 | 0.023 | Protease activated receptor 1 agonist | 0.013 0.007 CID_10013772 | ||
| 0.074 | 0.056 | 0.09 | GABA B receptor agonist | 0.09 0.026 CID_10013772 | CID_10013772 | |
| 0.068 | 0.049 | 0.078 | Phosphofructokinase-1 inhibitor | 0.078 0.042 CID_10013772 | CID_10013772 | |
| 0.041 | 0.023 | 0.041 | Carbonic anhydrase I stimulant | |||
| 0.102 | 0.083 | 0.102 | Acetylcholine release stimulant | |||
| 0.106 | 0.088 | 0.151 | Aldehyde dehydrogenase inhibitor | 0.151 0.047 CID_10013772 | CID_10013772 | |
| 0.09 | 0.073 | 0.09 | Sphingomyelinase inhibitor | |||
| 0.087 | 0.07 | 0.087 | Glutamate release inhibitor | |||
| 0.089 | 0.073 | 0.089 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.025 | 0.008 | 0.025 | Neuraminidase (Influenza B) inhibitor | 0.025 0.008 CID_10013772 | ||
| 0.068 | 0.052 | 0.068 | CXC chemokine receptor antagonist | |||
| 0.04 | 0.025 | 0.04 | Vascular adhesion protein 1 inhibitor | |||
| 0.049 | 0.033 | 0.049 | GP IIb/IIIa receptor antagonist | |||
| 0.042 | 0.027 | 0.042 | Integrin alpha5beta1 antagonist | 0.038 0.033 CID_10013772 | ||
| 0.044 | 0.029 | 0.044 | Dihydrofolate reductase inhibitor | |||
| 0.072 | 0.058 | 0.084 | Na+ K+ transporting ATPase inhibitor | 0.084 0.047 CID_10013772 | CID_10013772 | |
| 0.028 | 0.014 | 0.028 | Growth hormone releasing factor antagonist | 0.026 0.015 CID_10013772 | ||
| 0.027 | 0.013 | 0.027 | Complement factor 1s inhibitor | |||
| 0.038 | 0.024 | 0.038 | Glutamate (mGluR3) antagonist | 0.035 0.028 CID_10013772 | ||
| 0.065 | 0.052 | 0.065 | Glutamate (mGluR6) antagonist | |||
| 0.154 | 0.141 | 0.188 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.188 0.083 CID_10013772 | CID_10013772 | |
| 0.045 | 0.033 | 0.045 | Adenylate cyclase 1 inhibitor | 0.041 0.04 CID_10013772 | ||
| 0.073 | 0.06 | 0.094 | Somatostatin 1 agonist | 0.094 0.038 CID_10013772 | CID_10013772 | |
| 0.065 | 0.053 | 0.065 | Glutamate (mGluR7) antagonist | |||
| 0.13 | 0.118 | 0.158 | CF transmembrane conductance regulator agonist | 0.158 0.063 CID_10013772 | CID_10013772 | |
| 0.026 | 0.015 | 0.026 | Acid ceramidase inhibitor | |||
| 0.038 | 0.027 | 0.038 | Glutamate (mGluR8) agonist | 0.036 0.031 CID_10013772 | ||
| 0.043 | 0.032 | 0.044 | AICAR transformylase inhibitor | 0.044 0.031 CID_10013772 | CID_10013772 | |
| 0.019 | 0.008 | 0.019 | Prokineticin receptor 1 antagonist | |||
| 0.088 | 0.077 | 0.14 | Carbonic anhydrase III inhibitor | 0.14 0.033 CID_10013772 | CID_10013772 | |
| 0.044 | 0.034 | 0.048 | Neuraminidase (Influenza A) inhibitor | 0.048 0.027 CID_10013772 | CID_10013772 | |
| 0.042 | 0.032 | 0.042 | Heme oxygenase inhibitor | |||
| 0.038 | 0.028 | 0.038 | Cathepsin L1 inhibitor | |||
| 0.074 | 0.065 | 0.114 | Carbonic anhydrase VI inhibitor | 0.114 0.032 CID_10013772 | CID_10013772 | |
| 0.048 | 0.04 | 0.048 | 5 Hydroxytryptamine 2 agonist | |||
| 0.046 | 0.038 | 0.046 | Histamine H4 receptor antagonist | |||
| 0.031 | 0.022 | 0.031 | Bradykinin B2 receptor antagonist | |||
| 0.034 | 0.026 | 0.034 | Nociceptin (N/OFQ) receptor antagonist | |||
| 0.047 | 0.039 | 0.047 | Bombesin 2 receptor antagonist | 0.044 0.043 CID_10013772 | ||
| 0.05 | 0.043 | 0.088 | Maillard reaction inhibitor | 0.088 0.022 CID_10013772 | CID_10013772 | |
| 0.02 | 0.014 | 0.02 | Toll-Like receptor 8 agonist | |||
| 0.025 | 0.019 | 0.026 | Vanilloid 2 agonist | 0.026 0.017 CID_10013772 | CID_10013772 | |
| 0.031 | 0.027 | 0.031 | Gonadotropin-releasing hormone receptor antagonist | |||
| 0.049 | 0.045 | 0.049 | Alpha-mannosidase inhibitor | 0.049 0.046 CID_10013772 | ||
| 0.04 | 0.036 | 0.04 | Geranyltranstransferase inhibitor | |||
| 0.031 | 0.027 | 0.031 | Fumarate hydratase inhibitor | |||
| 0.097 | 0.093 | 0.101 | Histone deacetylase class III inhibitor | 0.101 0.089 CID_10013772 | CID_10013772 | |
| 0.039 | 0.035 | 0.039 | Kainate receptor agonist | |||
| 0.051 | 0.047 | 0.051 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | |||
| 0.112 | 0.109 | 0.127 | Vanilloid 1 agonist | 0.127 0.072 CID_10013772 | CID_10013772 | |
| 0.031 | 0.029 | 0.031 | Factor XI inhibitor | |||
| 0.018 | 0.016 | 0.018 | Neurokinin 1 agonist | |||
| 0.041 | 0.038 | 0.041 | Glutamate (mGluR group III) antagonist | |||
| 0.039 | 0.037 | 0.047 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.047 0.019 CID_10013772 | CID_10013772 | |
| 0.044 | 0.043 | 0.044 | Potassium channel (Inward rectifier) blocker | |||
| 0.066 | 0.065 | 0.07 | Metalloproteinase-9 inhibitor | 0.07 0.056 CID_10013772 | CID_10013772 | |
| 0.037 | 0.036 | 0.037 | Carbonic anhydrase IV inhibitor | |||
| 0.024 | 0.023 | 0.024 | Histamine H3 receptor agonist | |||
| 0.02 | 0.019 | 0.02 | Vasopressin 1 agonist | |||
| 0.01 | 0.009 | 0.01 | Imidazoline I2 receptor antagonist | |||
| 0.027 | 0.031 | 0.029 | Calcitonin receptor agonist | 0.029 0.028 CID_10013772 | CID_10013772 | |
| 0.123 | 0.128 | 0.17 | Melanin inhibitor | 0.17 0.059 CID_10013772 | CID_10013772 | |
| 0.037 | 0.042 | 0.054 | Glycine transporter 2 inhibitor | 0.054 0.028 CID_10013772 | CID_10013772 | |
| 0.03 | 0.035 | 0.043 | Opioid delta receptor agonist | 0.043 0.017 CID_10013772 | CID_10013772 | |
| 0.038 | 0.045 | 0.068 | Opioid mu receptor agonist | 0.068 0.021 CID_10013772 | CID_10013772 | |
| 0.07 | 0.078 | 0.081 | Ornithine decarboxylase inhibitor | 0.081 0.066 CID_10013772 | CID_10013772 | |
| 0.08 | 0.09 | 0.087 | UDP-glucose 4-epimerase inhibitor | 0.087 0.077 CID_10013772 | CID_10013772 | |
| 0.015 | 0.026 | 0.022 | Estrogen-related receptor gamma agonist | 0.022 0.008 CID_10013772 | CID_10013772 | |
| 0.042 | 0.054 | 0.055 | Carbonic anhydrase VB inhibitor | 0.055 0.039 CID_10013772 | CID_10013772 | |
| 0.184 | 0.198 | 0.203 | Antithrombotic | 0.203 0.173 CID_10013772 | CID_10013772 | |
| 0.081 | 0.095 | 0.101 | Anabolic | 0.101 0.061 CID_10013772 | CID_10013772 | |
| 0.05 | 0.064 | 0.058 | Purinergic P2X1 antagonist | 0.058 0.046 CID_10013772 | CID_10013772 | |
| 0.086 | 0.102 | 0.106 | Mucolytic | 0.106 0.069 CID_10013772 | CID_10013772 | |
| 0.056 | 0.072 | 0.067 | Beta 2 adrenoreceptor agonist | 0.067 0.025 CID_10013772 | CID_10013772 | |
| 0.053 | 0.072 | 0.064 | Carbonic anhydrase VA inhibitor | 0.064 0.054 CID_10013772 | CID_10013772 | |
| 0.092 | 0.116 | 0.111 | Cyclooxygenase 3 inhibitor | 0.111 0.088 CID_10013772 | CID_10013772 | |
| 0.081 | 0.105 | 0.153 | Cystathionine beta-synthase inhibitor | 0.153 0.039 CID_10013772 | CID_10013772 | |
| 0.029 | 0.058 | 0.047 | NMDA receptor subunit 3B antagonist | 0.047 0.027 CID_10013772 | CID_10013772 | |
| 0.158 | 0.188 | 0.185 | DNA synthesis inhibitor | 0.185 0.146 CID_10013772 | CID_10013772 | |
| 0.046 | 0.077 | 0.058 | Carbonic anhydrase V inhibitor | 0.058 0.056 CID_10013772 | CID_10013772 | |
| 0.051 | 0.084 | 0.085 | Carbonic anhydrase XIII inhibitor | 0.085 0.046 CID_10013772 | CID_10013772 | |
| 0.07 | 0.105 | 0.087 | D-Ala-D-Ala ligase inhibitor | 0.087 0.05 CID_10013772 | CID_10013772 | |
| 0.021 | 0.059 | 0.027 | Estrogen-related receptor gamma antagonist | 0.027 0.022 CID_10013772 | CID_10013772 | |
| 0.072 | 0.112 | 0.085 | Protein kinase C zeta inhibitor | 0.085 0.074 CID_10013772 | CID_10013772 | |
| 0.151 | 0.196 | 0.165 | RNA-directed DNA polymerase inhibitor | 0.165 0.163 CID_10013772 | CID_10013772 | |
| 0.105 | 0.15 | 0.127 | Arachidonic acid antagonist | 0.127 0.116 CID_10013772 | CID_10013772 | |
| 0.049 | 0.098 | 0.064 | Beta 3 adrenoreceptor antagonist | 0.064 0.046 CID_10013772 | CID_10013772 | |
| 0.055 | 0.106 | 0.093 | Adrenaline agonist | 0.093 0.042 CID_10013772 | CID_10013772 | |
| 0.026 | 0.081 | 0.054 | Opioid agonist | 0.054 0.035 CID_10013772 | CID_10013772 | |
| 0.029 | 0.086 | 0.048 | Beta 2 adrenoreceptor antagonist | 0.048 0.039 CID_10013772 | CID_10013772 | |
| 0.123 | 0.184 | 0.161 | Immunostimulant | 0.161 0.145 CID_10013772 | CID_10013772 | |
| 0.081 | 0.146 | 0.122 | Toll-Like receptor 2 antagonist | 0.122 0.076 CID_10013772 | CID_10013772 | |
| 0.053 | 0.122 | 0.074 | Keratolytic | 0.074 0.058 CID_10013772 | CID_10013772 | |
| 0.033 | 0.108 | 0.043 | Beta adrenoreceptor agonist | 0.043 0.04 CID_10013772 | CID_10013772 | |
| 0.105 | 0.179 | 0.129 | Interferon gamma antagonist | 0.129 0.113 CID_10013772 | CID_10013772 | |
| 0.065 | 0.143 | 0.083 | Vanilloid agonist | 0.083 0.061 CID_10013772 | CID_10013772 | |
| 0.048 | 0.128 | 0.089 | Macrophage migration inhibitory factor inhibitor | 0.089 0.042 CID_10013772 | CID_10013772 | |
| 0.053 | 0.142 | 0.083 | Alcohol dehydrogenase inhibitor | 0.083 0.075 CID_10013772 | CID_10013772 | |
| 0.028 | 0.132 | 0.05 | NMDA 2B receptor antagonist | 0.05 0.042 CID_10013772 | CID_10013772 | |
| 0.157 | 0.27 | 0.202 | Histamine release inhibitor | 0.202 0.2 CID_10013772 | CID_10013772 | |
| 0.038 | 0.17 | 0.101 | Monophenol monooxygenase inhibitor | 0.101 0.076 CID_10013772 | CID_10013772 | |
| 0.121 | 0.261 | 0.205 | 12-Lipoxygenase inhibitor | 0.205 0.146 CID_10013772 | CID_10013772 | |
| 0.049 | 0.218 | 0.1 | DNA polymerase I inhibitor | 0.1 0.086 CID_10013772 | CID_10013772 | |
| 0.059 | 0.242 | 0.155 | Angiogenesis stimulant | 0.155 0.119 CID_10013772 | CID_10013772 | |
| 0.019 | 0.36 | 0.101 | M18 aspartyl aminopeptidase inhibitor | 0.101 0.09 CID_10013772 | CID_10013772 | |
| 0.043 | 0.408 | 0.118 | Interleukin 4 antagonist | 0.118 0.088 CID_10013772 | CID_10013772 | |
| 0.008 | 0.533 | 0.031 | Estrogen-related receptor beta antagonist | 0.031 0.027 CID_10013772 | CID_10013772 | |
| 0.016 | 0.612 | 0.177 | Free radical scavenger | 0.177 0.117 CID_10013772 | CID_10013772 | |
| 0.008 | 0.693 | 0.117 | Estrogen receptor beta antagonist | 0.117 0.036 CID_10013772 | CID_10013772 | |
| 0.009 | 0.73 | 0.127 | Estrogen antagonist | 0.127 0.043 CID_10013772 | CID_10013772 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |